Evidence map›Paper›PMID 27040306›Full record

ArticleMolecular and cellular endocrinology2016

TRAF3IP2 mediates aldosterone/salt-induced cardiac hypertrophy and fibrosis.

Siva S V P Sakamuri, Anthony J Valente, Jalahalli M Siddesha, Patrice Delafontaine, Ulrich Siebenlist, Jason D Gardner, Chandrasekar Bysani

Abstract read
In one paragraph

Article in Molecular and cellular endocrinology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it, 32 citations in OpenAlex.

  1. A Review of CXCL1 in Cardiac Fibrosis.Frontiers in cardiovascular medicine · 2021
    Pooled it
  2. Article
  3. Glycolysis-Related Genes,Cardiology research · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Siva S V P SakamuriHeart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, United States.
Anthony J ValenteMedicine, University of Texas Health Science Center, San Antonio, TX 78229, United States.
Jalahalli M SiddeshaHeart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, United States.
Patrice DelafontaineHeart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, United States.
Ulrich SiebenlistLaboratory of Molecular Immunology, NIAID, NIH, Bethesda, MD 20892, United States.
Jason D GardnerPhysiology, Louisiana State University Health Sciences Center, New Orleans, LA 70112, United States.
Chandrasekar BysaniHeart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, United States. Electronic address: chandrasekarb@health.missouri.edu.
Tulane University · USLouisiana State University Health Sciences Center New Orleans · USNational Institutes of Health · USThe University of Texas Health Science Center at San Antonio · US

Funding

Insulin-Like Growth Factor-1and AtherosclerosisR01HL070241 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI PATRICE DELAFONTAINE · 2003 to 2026
$10.1M
Functions of IL-17 Family Cytokines in Health and DiseaseZIAAI001095 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI SIEBENLIST, ULRICH · 2009 to 2020
$9.7M
Vascular and Cardiac Function Core - "Mentoring in Cardiovascular BiologyP30GM106392 · NIGMS · LSU HEALTH SCIENCES CENTER · PI KAPUSTA, DANIEL R · 2014 to 2018
$5.5M
ANGIOTENSIN II, IGF-1 AND SKELETAL MUSCLE ATROPHYR01HL080682 · NHLBI · UNIVERSITY OF MISSOURI-COLUMBIA · PI DELAFONTAINE, PATRICE · 2007 to 2015
$3.3M
The Role of Interleukin-18 in Myocardial Hypertrophy and FailureR01HL086787 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI BYSANI, CHANDRASEKAR · 2009 to 2013
$1.8M
TRAF3IP2 in Ischemic Heart DiseaseI01BX002255 · VA · SOUTHEAST LOUISIANA VETERANS HEALTH CARE · PI BYSANI, CHANDRASEKAR · 2014 to 2017
–
BLRD VA I01 BX002255NHLBI NIH HHS R01 HL070241NHLBI NIH HHS R01 HL080682NHLBI NIH HHS R01 HL086787NIGMS NIH HHS P30 GM106392
6 · The paper itself

Abstract

Aberrant activation of the renin-angiotensin-aldosterone system (RAAS) contributes to adverse cardiac remodeling and eventual failure. Here we investigated whether TRAF3 Interacting Protein 2 (TRAF3IP2), a redox-sensitive cytoplasmic adaptor molecule and an upstream regulator of nuclear factor-κB (NF-κB) and activator protein-1 (AP-1), mediates aldosterone-induced cardiac hypertrophy and fibrosis. Wild type (WT) and TRAF3IP2-null mice were infused with aldosterone (0.2 mg/kg/day) for 4 weeks along with 1%NaCl in drinking water. Aldosterone/salt, but not salt alone, upregulated TRAF3IP2 expression in WT mouse hearts. Further, aldosterone elevated blood pressure to a similar extent in both WT and TRAF3IP2-null groups. However, TRAF3IP2 gene deletion attenuated aldosterone/salt-induced (i) p65 and c-Jun activation, (ii) extracellular matrix (collagen Iα1 and collagen IIIα1), matrix metalloproteinase (MMP2), lysyl oxidase (LOX), inflammatory cytokine (IL-6 and IL-18), chemokine (CXCL1 and CXCL2), and adhesion molecule (ICAM1) mRNA expression in hearts, (iii) IL-6, IL-18, and MMP2 protein levels, (iv) systemic IL-6 and IL-18 levels, and (iv) cardiac hypertrophy and fibrosis. These results indicate that TRAF3IP2 is a critical signaling intermediate in aldosterone/salt-induced myocardial hypertrophy and fibrosis, and thus a potential therapeutic target in hypertensive heart disease.

Indexed as

Adaptor Proteins, Signal TransducingAldosteroneAnimalsBlood PressureCardiomegalyCell Adhesion MoleculesCytokinesExtracellular MatrixFibrosisGene Expression RegulationInflammation MediatorsMatrix Metalloproteinase 2Mice, Inbred C57BLNF-kappa BReceptor, Angiotensin, Type 1Sodium ChlorideAdaptor Proteins, Signal TransducingAldosteroneCell Adhesion MoleculesCytokinesInflammation MediatorsMatrix Metalloproteinase 2NF-kappa BReceptor, Angiotensin, Type 1Sodium ChlorideTraf3ip2 protein, mouseTranscription Factor AP-1Act1AldosteroneCardiac fibrosisCardiac hypertrophyCIKSRAASTRAF3IP2

Identifiers

PMID27040306
PMCPMC4861697
OpenAlexW2320006744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.